Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function

Diabetes

Volumn 57, Issue 11, 2008, Pages 3083-3089

  Kodl, Christopher T ^a   Franc, Daniel T ^b   Rao, Jyothi P ^a   Anderson, Fiona S ^a   Thomas, William ^c   Mueller, Bryon A ^b   Lim, Kelvin O ^b,d   Seaquist, Elizabeth R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ANISOTROPY; ARTICLE; BRAIN DAMAGE; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; TASK PERFORMANCE; WHITE MATTER; AGE; BRAIN; COGNITION; DIFFUSION WEIGHTED IMAGING; METHODOLOGY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ADULT; AGE FACTORS; ANISOTROPY; BRAIN; COGNITION; DIABETES MELLITUS, TYPE 1; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 58149359256     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0724     Document Type: Article

References (45)

1. Brands AM, Kessels RP, Hoogma RP, Henselmans JM, van der Beek Boter JW, Kappelle LJ, de Haan EH, Biessels GJ: Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 55:1800-1806, 2006
2. Ryan CM, Geckle MO, Orchard TJ: Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46:940-948, 2003
3. Ryan CM, Williams TM, Finegold DN, Orchard TJ: Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 36:329-334, 1993
4. Wessels AM, Rombouts SA, Remijnse PL, Boom Y, Scheltens P, Barkhof F, Heine RJ, Snoek FJ: Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 20:1763-1769, 2007
5. Hershey T, Bhargava N, Sadler M, White NH, Craft S: Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care 22:1318-1324, 1999
6. Ryan CM: Neurobehavioral complications of type I diabetes: examination of possible risk factors. Diabetes Care 11:86-93, 1988
7. Skenazy JA, Bigler ED: Neuropsychological findings in diabetes mellitus. J Clin Psychol 40:246-258, 1984
8. Northam EA, Anderson PJ, Werther GA, Warne GL, Adler RG, Andrewes D: Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 21:379-384, 1998
9. Northam EA, Anderson PJ, Jacobs R, Hughes M, Warne GL, Werther GA: Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 24:1541-1546, 2001
10. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH: Cerebral function in diabetes mellitus. Diabetologia 37:643-650, 1994
11. Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP: Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry 51:890-895, 2002
12. Wozniak JR, Lim KO: Advances in white matter imaging: a review ofin vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci Biobehav Rev 30:762-774, 2006
13. Hoptman MJ, Ardekani BA, Butler PD, Nierenberg J, Javitt DC, Lim KO: DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis. Neuroreport 15:2467-2470, 2004
14. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A: Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 56:367-374, 1999
15. Alexopoulos GS, Kiosses DN, Choi SJ, Murphy CF, Lim KO: Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am, J Psychiatry 159:1929-1932, 2002
16. Pfefferbaum A, Sullivan EV, Hedehus M, Lim KO, Adalsteinsson E, Moseley M: Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn Reson Med 44:259-268, 2000
17. Chen SQ, Kang Z, Hu XQ, Hu B, Zou Y: Diffusion tensor imaging of the brain in patients with Alzheimer's disease and cerebrovascular lesions. J Zhejiang Univ Sci B 8:242-247, 2007
18. Stahl R, Dietrich O, Teipel SJ, Hampel H, Reiser MF, Schoenberg SO: White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 243:483-492, 2007
19. Moeller FG, Hasan KM, Steinberg JL, Kramer LA, Dougherty DM, Santos RM, Valdes I, Swann AC, Barratt ES, Narayana PA: Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: diffusion tensor imaging. Neuropsychopharmacology 30:610-617, 2005
20. Filippi CG, Ulug AM, Ryan E, Ferrando SJ, van Gorp W: Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. Am J Neuroradiol 22:277-283, 2001
21. Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J: Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356:1842-1852, 2007
22. deGroot JC, DeLeeuw F, Oudkerk M, van Gijn J, Hofman A, Jolles J, Breteler MM: Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 47:145-151, 2000
23. Desmond DW: Cognition and white matter lesions. Cerebrovasc Dis 13 (Suppl. 2):53-57, 2002
24. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM: Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 (Suppl. 1):S208-S219, 2004
25. Haselgrove JC, Moore JR: Correction for distortion of echo-planar images used to calculate the apparent diffusion coefficient. Magn Reson Med 36:960-964, 1996
26. Basser PJ, Pierpaoli C: Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 111:209-219, 1996
27. Smith SM, Johansen-Berg H, Jenkinson M, Rueckert D, Nichols TE, Miller KL, Robson MD, Jones DK, Klein JC, Bartsch AJ, Behrens TE: Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2:499-503, 2007
28. Mori S, Wakana S, van Zijl PCM, Nagae-Poetscher LM: MRI Atlas of Human White Matter. Amsterdam, Elsevier, 2005
29. Witelson SF: Hand and sex differences in the isthmus and genu of the human corpus callosum: a postmortem morphological study. Brain 112: 799-835, 1989
30. Keymeulen B, de Metz K, Cluydts R, Bossuyt A, Somers G: Technetium- 99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes. Eur J Nucl Med 23:163-168, 1996
31. Sabri O, Hellwig D, Schreckenberger M, Schneider R, Kaiser HJ, Wagen- knecht G, Mull M, Buell U: Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl Med Commun 21:19-29, 2000
32. Chabriat H, Sachon C, Levasseur M, Grimaldi A, Pappata S, Rougemont D, Masure MC, De Recondo A, Samson Y: Brain metabolism after recurrent insulin induced hypoglycaemic episodes: a PET study. JNeurol Neurosurg Psychiatry 57:1360-1365, 1994
33. Weinger K, Jacobson AM, Musen G, Lyoo IK, Ryan CM, Jimerson DC, Renshaw PF: The effects of type 1 diabetes on cerebral white matter. Diabetologia 51:417-425, 2008
34. Yousem DM, Tasman WS, Grossman RI: Proliferative retinopathy: absence of white matter lesions at MR imaging. Radiology 179:229-230, 1991
35. Ferguson SC, Blane A, Wardlaw J, Frier BM, Perros P, McCrimmon RJ, Deary IJ: Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 28:1431-1437, 2005
36. Lobnig BM, Kromeke O, Optenhostert-Porstt C, Wolf OT: Hippocampal volume and cognitive performance in long-standing type 1 diabetic patients without macrovascular complications. Diabet Med 23:32-39, 2005
37. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, Ryan CM, Jimerson DC, Hennen J, Renshaw PF, Jacobson AM: Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55:326-333, 2006
38. Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ, Rombouts SA: Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49:2474-2480, 2006
39. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005
40. Kashem MA, James G, Harper C, Wilce P, Matsumoto I: Differential protein expression in the corpus callosum (splenium) of human alcoholics: a proteomics study. Neurochem Int 50:450-459, 2007
41. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R: Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 8:365-370, 2003
42. Casadesus G, Moreira PI, Nunomura A, Siedlak SL, Bligh-Glover W, Balraj E, Petot G, Smith MA, Perry G: Indices of metabolic dysfunction and oxidative stress. Neurochem Res 32:717-722, 2007
43. Poon HF, Abdullah L, Mullan MA, Mullan MJ, Crawford FC: Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells. Neurochem Int 50:69-73, 2007
44. Sarandol A, Kirli S, Akkaya C, Altin A, Demirci M, Sarandol E: Oxidative- antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment. Prog Neuropsychopharmacol Biol Psychiatry 31:1164-1169, 2007
45. Steiner J, Haughey N, Li W, Venkatesan A, Anderson C, Reid R, Malpica T, Pocernich C, Butterfield DA, Nath A: Oxidative stress and therapeutic approaches in HIV dementia. Antioxid Redox Signal 8:2089-2100, 2006